SCHEMBL30910095

SCHEMBL30910095

CC(Br)C(=O)N1CCN(c2ccccc2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ MAPT P10636 4/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ LMNA P02545 4/20 0.37
▸ TSHR P16473 4/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HTT P42858 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26088399 1.00 MEN1 (0.40) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL26091005 0.89 MAPT (0.43) MAPTLMNATSHRALDH1A1NPSR1
SCHEMBL30910101 0.89 MAPT (0.43) MAPTLMNATSHRALDH1A1NPSR1
SCHEMBL26088519 0.86 AVPR1A (0.42) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL30378648 0.86 AVPR1A (0.42) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL26092208 0.82 GAA (0.47) MEN1KMT2AMAPTLMNATSHR
SCHEMBL30379742 0.82 GAA (0.47) MEN1KMT2AMAPTLMNATSHR
SCHEMBL26088160 0.81 GAA (0.46) MEN1KMT2AMAPTLMNATSHR
SCHEMBL30910050 0.81 GAA (0.46) MEN1KMT2AMAPTLMNATSHR
SCHEMBL30379637 0.80 KMT2A (0.47) MEN1KMT2AMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SAPIENSBIO INC. (KR) 2025-01-02 — — US disclosed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME RHOA, ACTR2, MFAP1 MEN1 4510/4885KMT2A 3762/4885NPC1 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback